KKR to Acquire Integer Holdings for $5.7 Billion in All-Cash Deal

Key Facts

1Integer Holdings Corp. has agreed to be acquired by global investment firm KKR in an all-cash transaction.

2The transaction is valued at approximately $5.7 billion, with stockholders receiving $127 per share.

3Upon completion, Integer will become a privately held company and delist from the New York Stock Exchange.

In a move reflecting the continued appetite of private equity firms for the medical technology sector, Integer Holdings Corp. has agreed to be acquired by global investment firm KKR. According to reports, the all-cash transaction is valued at approximately $5.7 billion, with stockholders set to receive $127 per share. The acquisition aims to provide Integer with enhanced flexibility and capital to invest in capacity and innovation as a private entity.

Under the terms of the agreement, Integer will become a privately held company and will be delisted from the New York Stock Exchange upon completion. This transition is expected to strengthen the company's position as a medical device outsourced manufacturer. Per analyst data, the deal offers a clear cash premium for shareholders amid a market environment focused on medical supply chain efficiency.

Operationally, while current price levels are unavailable at this snapshot, market attention remains on the regulatory path toward closing the deal. On the macroeconomic front, investors are monitoring upcoming catalysts including the US ISM Manufacturing PMI scheduled for August 3, 2026, which may provide broader context for the manufacturing sector as Integer prepares for its delisting.

Sources:

Today's Medical Developments